The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Open accessAbstract
Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and microenvironmental features determine the propensity of RCD to drive adaptive immunity. Here, we provide an updated operational definition of immunogenic cell death (ICD), discuss the key factors that dictate the ability of dying cells to drive an adaptive immune response, summarize experimental assays that are currently available for the assessment of ICD in vitro and in vivo, and formulate guidelines for their interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–332 of 332
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
Teo, Z. L., Versaci, S., Dushyanthen, S., Caramia, F., Savas, P., Mintoff, C. P., Zethoven, M., Virassamy, B., Luen, S. J., McArthur, G. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2210 · Cited by 196
Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
van Lummel, M., Duinkerken, G., van Veelen, P. A., de Ru, A., Cordfunke, R., Zaldumbide, A., Gomez-Touriño, I., Arif, S., Peakman, M., Drijfhout, J. W., et al. (2014) · Diabetes · doi:10.2337/db12-1214 · Cited by 195
Strange attractors: DAMPs and autophagy link tumor cell death and immunity
Hou, W., Zhang, Q., Yan, Z., Chen, R., Zeh III, H. J., Kang, R., Lotze, M. T., & Tang, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.493 · Cited by 193
Self-citationThe immunopeptidomic landscape of ovarian carcinomas
Schuster, H., Peper, J. K., Bösmüller, H.-C., Röhle, K., Backert, L., Bilich, T., Ney, B., Löffler, M. W., Kowalewski, D. J., Trautwein, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707658114 · Cited by 189
Measles virus causes immunogenic cell death in human melanoma
Donnelly, O. G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V, Scott, K., Peach, H., Phillips, R. M., Bond, J., Pandha, H., et al. (2013) · Gene Therapy · doi:10.1038/gt.2011.205 · Cited by 187
Self-citationWoller, N., Gürlevik, E., Fleischmann-Mundt, B., Schumacher, A., Knocke, S., Kloos, A. M., Saborowski, M., Geffers, R., Manns, M. P., Wirth, T. C., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.115 · Cited by 186
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Segovia, C., San José-Enériz, E., Munera-Maravilla, E., Martínez-Fernández, M., Garate, L., Miranda, E., Vilas-Zornoza, A., Lodewijk, I., Rubio, C., Segrelles, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0499-y · Cited by 186
Self-citationContribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Yang, H., Ma, Y., Chen, G., Zhou, H., Yamazaki, T., Klein, C., Pietrocola, F., Vacchelli, E., Souquere, S., Sauvat, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1149673 · Cited by 185
Self-citationGenome-Derived Cytosolic DNA Mediates Type I Interferon-Dependent Rejection of B Cell Lymphoma Cells
Shen, Y. J., Le Bert, N., Chitre, A. A., Koo, C. X., Nga, X. H., Ho, S. S. W., Khatoo, M., Tan, N. Y., Ishii, K. J., & Gasser, S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.041 · Cited by 184
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Prestwich, R. J., Errington, F., Ilett, E. J., Morgan, R. S. M., Scott, K. J., Kottke, T., Thompson, J., Morrison, E. E., Harrington, K. J., Pandha, H. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0831 · Cited by 184
Self-citationPharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
Self-citationParlato, S., De Ninno, A., Molfetta, R., Toschi, E., Salerno, D., Mencattini, A., Romagnoli, G., Fragale, A., Roccazzello, L., Buoncervello, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01013-x · Cited by 181
Self-citationDuewell, P., Steger, A., Lohr, H., Bourhis, H., Hoelz, H., Kirchleitner, S. V., Stieg, M. R., Grassmann, S., Kobold, S., Siveke, J. T., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.96 · Cited by 179
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Lam, A. R., Le Bert, N., Ho, S. S. W., Shen, Y. J., Tang, M. L. F., Xiong, G. M., Croxford, J. L., Koo, C. X., Ishii, K. J., Akira, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1703 · Cited by 179
Ali, N., Flutter, B., Sanchez Rodriguez, R., Sharif-Paghaleh, E., Barber, L. D., Lombardi, G., & Nestle, F. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044219 · Cited by 175
Bondanza, A., Zimmermann, V. S., Rovere-Querini, P., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W., Pöschl, E., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040327 · Cited by 175
Self-citationdel Barrio, I. M., Penski, C., Schlahsa, L., Stein, R. G., Diessner, J., Wöckel, A., Dietl, J., Lutz, M. B., Mittelbronn, M. G. A., Wischhusen, J., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0154-9 · Cited by 175
Trial watch: Peptide-based vaccines in anticancer therapy
Bezu, L., Kepp, O., Cerrato, G., Pol, J. G., Fucikova, J. P., Špíšek, R., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1511506 · Cited by 174
Self-citationBoone, B. A., Orlichenko, L., Schapiro, N. E., Loughran, P., Gianfrate, G. C., Ellis, J. T., Singhi, A. D., Kang, R., Tang, D., Lotze, M. T., et al. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.21 · Cited by 172
Self-citationHigh hydrostatic pressure induces immunogenic cell death in human tumor cells
Fucikova, J., Moserova, I., Truxova, I., Hermanova, I., Vancurova, I., Partlova, S., Fialova, A., Sojka, L., Cartron, P., Houska, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28766 · Cited by 170
Self-citationHost Immune Response to Infection and Cancer: Unexpected Commonalities
Goldszmid, R. S., Dzutsev, A., & Trinchieri, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.003 · Cited by 165
Liikanen, I., Ahtiainen, L., Hirvinen, M. L., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S., Koski, A., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.51 · Cited by 165
Self-citationEstablishment of a Human Allergy Model Using Human IL-3/GM-CSF–Transgenic NOG Mice
Ito, R., Takahashi, T., Katano, I., Kawai, K., Kamisako, T., Ogura, T., Ida-Tanaka, M., Suemizu, H., Nunomura, S., Ra, C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203543 · Cited by 165
Diaconu, I., Cerullo, V., Hirvinen, M. L. M., Escutenaire, S., Ugolini, M., Pesonen, S. K., Bramante, S., Parviainen, S., Kanerva, A., Loskog, A. S. I., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2975 · Cited by 162
Self-citationPGE2 induced in and released by dying cells functions as an inhibitory DAMP
Hangai, S., Ao, T., Kimura, Y., Matsuki, K., Kawamura, T., Negishi, H., Nishio, J., Kodama, T., Taniguchi, T., & Yanai, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602023113 · Cited by 161
Trial watch: dendritic cell vaccination for cancer immunotherapy
Sprooten, J., Ceusters, J., Coosemans, A., Agostinis, P., Vleeschouwer, S. D., Zitvogel, L., Kroemer, G., Galluzzi, L., & Garg, A. D. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1638212 · Cited by 161
Self-citationPrognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Fucikova, J., Moserova, I., Urbanova, L., Bezu, L., Kepp, O., Cremer, I., Salek, C., Strnad, P., Kroemer, G., Galluzzi, L., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00402 · Cited by 159
Self-citationvan Schadewijk, A., van’t Wout, E. F. A., Stolk, J., & Hiemstra, P. S. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0306-2 · Cited by 158
Briere, D. M., Sudhakar, N., Woods, D. M., Hallin, J. F., Engstrom, L. D., Aranda, R., Chiang, H., Sodré, A. L., Olson, P., Weber, J. S., et al. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2091-y · Cited by 158
The oncolytic peptide LTX-315 triggers immunogenic cell death
Zhou, H., Forveille, S., Sauvat, A., Yamazaki, T., Senovilla, L., Ma, Y., Liu, P., Yang, H., Bezu, L., Müller, K., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.47 · Cited by 157
Self-citationHoecke, L. V., Lint, S. V., Roose, K., Parys, A. V., Vandenabeele, P., Grooten, J., Tavernier, J. H., Koker, S. D., & Saelens, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05979-8 · Cited by 156
Self-citationWculek, S. K., Amores, J., Conde‐Garrosa, R., Khouili, S. C., Melero, I., & Sancho, D. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0565-5 · Cited by 153
SnapShot: CGAS-STING Signaling
Galluzzi, L., Vanpouille‐Box, C., Bakhoum, S. F. W., & Demaria, S. (2018) · Cell · doi:10.1016/j.cell.2018.03.015 · Cited by 152
Self-citationLorenzi, S., Mattei, F., Sistigu, A., Bracci, L., Spadaro, F., Sanchez, M., Spada, M., Belardelli, F., Gabriele, L., & Schiavoni, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004163 · Cited by 151
Self-citationAutoantigenesis: the evolution of protein modifications in autoimmune disease
Doyle, H. A., & Mamula, M. J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.003 · Cited by 149
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 149
Rodriguez-Ruiz, M. E., Buqué, A., Hensler, M., Chen, J., Bloy, N., Petroni, G., Sato, A., Yamazaki, T., Fucikova, J., & Galluzzi, L. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1655964 · Cited by 147
Self-citationKrombach, J., Hennel, R., Brix, N., Orth, M., Schötz, U., Ernst, A., Schuster, J., Zuchtriegel, G., Reichel, C. A., Bierschenk, S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1523097 · Cited by 145
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
Sukkurwala, A. Q., Adjemian, S., Senovilla, L., Michaud, M., Spaggiari, S., Vacchelli, E., Baracco, E. E., Galluzzi, L., Zitvogel, L., Kepp, O., et al. (2014) · OncoImmunology · doi:10.4161/onci.28473 · Cited by 144
Self-citationIdentification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Malaker, S. A., Penny, S. A., Steadman, L. G., Myers, P. T., Loke, J. C. T., Raghavan, M., Bai, D. L., Shabanowitz, J., Hunt, D. F., & Cobbold, M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0280 · Cited by 143
Trial watch: Cardiac glycosides and cancer therapy
Menger, L., Vacchelli, E., Kepp, O., Eggermont, A. M. M., Tartour, É., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.23082 · Cited by 141
Self-citationChen, H., Wang, P.-H., Chen, S.-S., Wen, C.-C., Chen, Y., Yang, W., & Yang, N. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1258-9 · Cited by 141
An intact immune system is required for the anticancer activities of histone deacetylase inhibitors
West, A. C., Mattarollo, S. R., Shortt, J., Cluse, L. A., Christiansen, A. J., Smyth, M. J., & Johnstone, R. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0890 · Cited by 137
Self-citationFucikova, J., Truxova, I., Hensler, M., Becht, E., Kasikova, L., Moserova, I., Vosahlikova, S., Klouckova, J., Church, S. E., Cremer, I., et al. (2016) · Blood · doi:10.1182/blood-2016-08-731737 · Cited by 135
Self-citationWémeau, M., Kepp, O., Tesnière, A., Panaretakis, T., Flament, C., de Botton, S., Zitvogel, L., Kroemer, G., & Chaput, N. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.82 · Cited by 135
Self-citationBraciale, T. J., & Hahn, Y. S. (2013) · Immunological Reviews · doi:10.1111/imr.12109 · Cited by 135
Tufi, R., Panaretakis, T., Bianchi, K., Criollo, A., Fazi, B., Sano, F. D., Tesnière, A., Kepp, O., Paterlini-Bréchot, P., Zitvogel, L., et al. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402275 · Cited by 132
Self-citationBugaut, H., Bruchard, M., Berger, H., Dérangère, V., Odoul, L., Euvrard, R., Ladoire, S., Chalmin, F., Végran, F., Rébé, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065181 · Cited by 130
(2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2165 · Cited by 127
Zervoudi, E., Saridakis, E., Birtley, J. R., Seregin, S. S., Reeves, E., Kokkala, P., Aldhamen, Y. A., Amalfitano, A., Mavridis, I. M., James, E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309781110 · Cited by 125
Sagwal, S. K., Pasqual-Melo, G., Bodnar, Y., Gandhirajan, R. K., & Bekeschus, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1221-6 · Cited by 125
Stone, J. D., Harris, D. T., & Kranz, D. M. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.003 · Cited by 122
Garg, A. D., Vandenberk, L., Fang, S., Fasche, T., Van Eygen, S., Maes, J., Van Woensel, M., Koks, C., Vanthillo, N., Graf, N., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.15 · Cited by 120 · cited 2×
“151 158 Of note, some emitted DAMPs are immunosuppressive (eg , adenosine), 169 while others can switch to anti-inflammatory depending on the engaged PRR (eg , HMGB1), biochemical modifications such as oxidation (eg , HMGB1) or chronic release (eg , type I IFN).”
Self-citationSabatos-Peyton, C. A., Nevin, J. T., Brock, A., Venable, J. D., Tan, D. J., Kassam, N., Xu, F., Taraszka, J. A., Wesemann, L. D., Pertel, T., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1385690 · Cited by 119
Nam, G., Lee, E. J., Kim, Y. K., Hong, Y., Choi, Y., Ryu, M., Woo, J., Cho, Y., Ahn, D. J., Yang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04607-9 · Cited by 117
Ladoire, S., Penault-Llorca, F. M., Senovilla, L., Dalban, C., Enot, D. P., Locher, C., Prada, N., Poirier-Colame, V., Chaba, K., Arnould, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082022 · Cited by 116
Self-citationChristiansen, A. J., West, A. C., Banks, K.-M., Haynes, N. M., Teng, M. W. L., Smyth, M. J., & Johnstone, R. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011037108 · Cited by 116
Self-citationApoptosis in response to microbial infection induces autoreactive TH17 cells
Campisi, L., Barbet, G., Ding, Y., Esplugues, E., Flavell, R. A., & Blander, J. M. (2016) · Nature Immunology · doi:10.1038/ni.3512 · Cited by 112
Guo, S., Jing, Y., Burcus, N. I., Lassiter, B. P., Tanaz, R., Heller, R. F., & Beebe, S. J. (2017) · International Journal of Cancer · doi:10.1002/ijc.31071 · Cited by 111
Bloy, N., Garcia, P., Laumont, C. M., Pitt, J. M., Sistigu, A., Stoll, G., Yamazaki, T., Bonneil, É., Buqué, A., Humeau, J., et al. (2017) · Immunological Reviews · doi:10.1111/imr.12582 · Cited by 111
Self-citationSukkurwala, A. Q., Martins, I., Wang, Y., Schlemmer, F., Ruckenstuhl, C., Durchschlag, M., Michaud, M., Senovilla, L., Sistigu, A., Ma, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.73 · Cited by 109
Self-citationPremortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
Martins, I., Michaud, M., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Shen, S., Kepp, O., Menger, L., Vacchelli, E., Galluzzi, L., et al. (2012) · Autophagy · doi:10.4161/auto.19009 · Cited by 107
Self-citationSchildkopf, P., Frey, B., Ott, O. J., Rubner, Y., Multhoff, G., Sauer, R., Fietkau, R., & Gaipl, U. S. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.056 · Cited by 105
Self-citationDudek-Perić, A. M., Ferreira, G. B., Muchowicz, A., Wouters, J., Prada, N., Martin, S., Kiviluoto, S., Winiarska, M., Boon, L., Mathieu, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2089 · Cited by 104
Self-citationHo, W. S., Wang, H., Maggio, D. M., Kovach, J. S., Zhang, Q., Song, Q., Marincola, F. M., Heiss, J. D., Gilbert, M. R., Lu, R. O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04425-z · Cited by 101
Self-citationMutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy
Vitale, I., Sistigu, A., Manic, G., Rudqvist, N.-P., Trajanoski, Z., & Galluzzi, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.01.003 · Cited by 101
Self-citationSUZUKI, S., YOKOBORI, T., TANAKA, N., SAKAI, M., SANO, A., INOSE, T., SOHDA, M., NAKAJIMA, M., MIYAZAKI, T., KATO, H., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1831 · Cited by 100
T cells specific for post-translational modifications escape intrathymic tolerance induction
Raposo, B., Merky, P., Lundqvist, C., Yamada, H., Urbonaviciute, V., Niaudet, C., Viljanen, J., Kihlberg, J. O., Kyewski, B., Ekwall, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02763-y · Cited by 99
Rodriguez-Ruiz, M. E., Rodríguez, I., Mayorga, L., Labiano, T., Barbés, B., Etxeberría, I., Ponz‐Sarvisé, M., Azpilikueta, A., Bolaños, E., Sanmamed, M. F., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0558 · Cited by 99
Tressler, A. B., Peñuela, S., Laird, D. W., & Dubyak, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590240 · Cited by 97
Modeling Tumor Immunology and Immunotherapy in Mice
Buqué, A., & Galluzzi, L. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.07.003 · Cited by 94
Self-citationWerthmöller, N., Frey, B., Wunderlich, R., Fietkau, R., & Gaipl, U. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.129 · Cited by 92
Self-citationMalamas, A. S., Gameiro, S. R., Knudson, K. M., & Hodge, J. W. (2016) · Oncotarget · doi:10.18632/oncotarget.13520 · Cited by 91
Self-citationImmune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
Aranda, F., Bloy, N., Pesquet, J., Petit, B., Chaba, K., Sauvat, A., Kepp, O., Khadra, N., Enot, D., Pfirschke, C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.234 · Cited by 89
Self-citationSagiv-Barfi, I., Kohrt, H. E. K., Burckhardt, L., Czerwinski, D. K., & Levy, R. (2015) · Blood · doi:10.1182/blood-2014-08-593137 · Cited by 87
Garg, A. D., Elsen, S., Krysko, D. V., Vandenabeele, P., de Witte, P., & Agostinis, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4754 · Cited by 87
Self-citationAnimal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 YearsPreprint
Kemp, C. J. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069906 · Cited by 85
Bauer, C. A., Bauernfeind, F. G., Sterzik, A., Orban, M., Schnurr, M., Lehr, H., Endres, S., Eigler, A., & Dauer, M. (2007) · Gut · doi:10.1136/gut.2006.108621 · Cited by 85
Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
Wang, H., Tan, M., Zhang, S., Li, X., Gao, J., Zhang, D., Hao, Y., Gao, S., Liu, J., & Lin, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023391 · Cited by 83
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer
Ishak, C. A., Classon, M., & Carvalho, D. D. D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.008 · Cited by 83
Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance
Starck, S. R., & Shastri, N. (2016) · Immunological Reviews · doi:10.1111/imr.12434 · Cited by 82
Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice
Saito, Y., Ellegast, J. M., Rafiei, A., Song, Y., Kull, D., Heikenwälder, M. F., Rongvaux, A., Halene, S., Flavell, R. A., & Manz, M. G. (2016) · Blood · doi:10.1182/blood-2015-10-676452 · Cited by 81
Immune oncology, immune responsiveness and the theory of everything
Turan, T., Kannan, D., Patel, M. R., Barnes, J. M., Tanlimco, S. G., Lu, R. O., Halliwill, K. D., Kongpachith, S., Kline, D. E., Hendrickx, W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0355-5 · Cited by 81
Self-citationNorm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells
Kulzer, L., Rubner, Y., Deloch, L., Allgäuer, A., Frey, B., Fietkau, R., Dörrie, J., Schaft, N., & Gaipl, U. S. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.880533 · Cited by 80
Self-citationNeoantigens encoded in the cancer genome
Schumacher, T. N., & Hacohen, N. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.07.005 · Cited by 80
Colangelo, T., Polcaro, G., Ziccardi, P., Muccillo, L., Galgani, M., Pucci, B., Milone, M. R., Budillon, A., Santopaolo, M., Mazzoccoli, G., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.29 · Cited by 78
Rubner, Y., Muth, C., Strnad, A. R., Derer, A., Sieber, R., Buslei, R., Frey, B., Fietkau, R., & Gaipl, U. S. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-89 · Cited by 76
Self-citationDying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity
Yatim, N., & Albert, M. L. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.010 · Cited by 72
D’Eliseo, D., Manzi, L., & Velotti, F. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0422-2 · Cited by 72
D'Almeida, S. M., Kauffenstein, G., Roy, C., Basset, L., Papargyris, L., Henrion, D., Catros, V., Ifrah, N., Descamps, P., Croué, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178025 · Cited by 72
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation
Ko, E. C., Benjamin, K. T., & Formenti, S. C. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.08.021 · Cited by 71
Self-citationImmunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus
Hirvinen, M., Rajecki, M., Kapanen, M. K., Parviainen, S., Rouvinen-Lagerström, N., Diaconu, I., Nokisalmi, P., Tenhunen, M., Hemminki, A., & Cerullo, V. (2015) · Human Gene Therapy · doi:10.1089/hum.2014.069 · Cited by 67
Self-citationLu, X., Ding, Z., Cao, Y., Liu, C., Habtetsion, T. G., Yu, M., Lemos, H. D. P., Salman, H., Xu, H., Mellor, A. L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401894 · Cited by 67
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells
Adkins, I., Sadilkova, L. K., Hradilova, N., Tomala, J., Kovář, M., & Špíšek, R. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1311433 · Cited by 65
Vancsik, T., Kővágó, C., Kiss, E., Papp, E., Forika, G., Benyó, Z., Meggyesházi, N., & Krenács, T. (2017) · Journal of Cancer · doi:10.7150/jca.21520 · Cited by 65
Mattei, F., Schiavoni, G., Sestili, P., Spadaro, F., Fragale, A., Sistigu, A., Lucarini, V., Spada, M., Sanchez, M., Scala, S., et al. (2012) · Neoplasia · doi:10.1593/neo.121444 · Cited by 64
Self-citationAnalysis of Chaperone-Mediated Autophagy
Juste, Y. R., & Cuervo, A. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8873-0_47 · Cited by 64
Kang, R., Chen, R., Xie, M., Cao, L., Lotze, M. T., Tang, D., & Zeh, H. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502340 · Cited by 62
Self-citationConserved and divergent aspects of human T‐cell development and migration in humanized mice
Halkias, J., Yen, B., Taylor, K. T., Reinhartz, O., Winoto, A., Robey, E. A., & Melichar, H. J. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.38 · Cited by 61
Fucikova, J. P., Kašíková, L., Truxová, I., Laco, J., Škapa, P., Ryška, A., & Špíšek, R. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.006 · Cited by 61
Self-citationRiganti, C., Lingua, M. F., Salaroglio, I. C., Falcomatà, C., Righi, L., Morena, D., Picca, F., Oddo, D., Kopecka, J., Pradotto, M., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1398874 · Cited by 59
Self-citationVentura, A., Vassall, A. N., Robinson, E., Filler, R. B., Hanlon, D. J., Meeth, K. M., Ezaldein, H. H., Girardi, M., Sobolev, O., Bosenberg, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0171 · Cited by 59
Self-citationContribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Ma, Y., Aymeric, L., Locher, C., Mattarollo, S. R., Delahaye, N. F., Pereira, P., Boucontet, L., Apétoh, L., Ghiringhelli, F., Casares, N., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.201002692084c · Cited by 58
Self-citationJohnny on the Spot-Chronic Inflammation Is Driven by HMGB1
Gorgulho, C. M., Romagnoli, G. G., Bharthi, R., & Lotze, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01561 · Cited by 57
Self-citationTruxova, I., Kasikova, L., Salek, C., Hensler, M., Lysak, D., Holicek, P., Bilkova, P., Holubova, M., Chen, X., Mikyskova, R., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.223933 · Cited by 56
Self-citationSiurala, M., Bramante, S., Vassilev, L., Hirvinen, M., Parviainen, S., Tähtinen, S., Guse, K., Cerullo, V., Kanerva, A., Kipar, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29048 · Cited by 55
Self-citationTolerance: an overview and perspectives
Waldmann, H. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.108 · Cited by 54
A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription
Musahl, A.-S., Huang, X., Rusakiewicz, S., Ntini, E., Marsico, A., Kroemer, G., Kepp, O., & Ørom, U. A. (2015) · Oncogene · doi:10.1038/onc.2014.424 · Cited by 52
Self-citationControl of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges
Sicari, D., Igbaria, A., & Chevet, É. (2019) · Cells · doi:10.3390/cells8111347 · Cited by 52
Duewell, P., Beller, E., Kirchleitner, S. V., Adunka, T., Bourhis, H., Siveke, J. T., Mayr, D. C., Kobold, S., Endres, S., & Schnurr, M. M. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1029698 · Cited by 47
Fine-tuning of T cell responses during infection
Dorhoi, A., & Kaufmann, S. H. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.004 · Cited by 47
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
Kirkin, A. F., Dzhandzhugazyan, K. N., Guldberg, P., Fang, J., Andersen, R. S., Dahl, C., Mortensen, J., Lundby, T., Wagner, A., Law, I. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03217-9 · Cited by 46
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
Kopecka, J., Salaroglio, I. C., Righi, L., Libener, R., Orecchia, S., Grosso, F., Milošević, V., Ananthanarayanan, P., Ricci, L., Capelletto, E., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.03.022 · Cited by 45
Self-citationThe oncolytic compound LTX-401 targets the Golgi apparatus
Zhou, H., Sauvat, A., Gomes-da-Silva, L. C., Durand, S., Forveille, S., Iribarren, K., Yamazaki, T., Souquère, S., Bezu, L., Müller, K., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.86 · Cited by 43
Self-citationTFAM is a novel mediator of immunogenic cancer cell death
Yang, M., Li, C., Zhu, S., Cao, L., Kroemer, G., Zeh, H. J., Tang, D., & Kang, R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431086 · Cited by 43
Self-citationWeiss, E., Meister, S., Janko, C., Ebel, N., Schlücker, E., Meyer‐Pittroff, R., Fietkau, R., i, M. H., Gaipl, U. S., & Frey, B. (2010) · Journal of Immunotoxicology · doi:10.3109/15476911003657414 · Cited by 42
Self-citationThe oncolytic peptide LTX-315 triggers necrotic cell death
Forveille, S., Zhou, H., Sauvat, A., Bezu, L., Müller, K., Liu, P., Zitvogel, L., Pierron, G., Rekdal, Ø., Kepp, O., et al. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093710 · Cited by 42
Self-citationMoserova, I. K., Truxová, I., Garg, A. D., Tomala, J., Agostinis, P., Cartron, P., Vosahlikova, S., Kovář, M., Špíšek, R., & Fucikova, J. P. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1258505 · Cited by 42
Self-citationChen, X., Fosco, D., Kline, D. E., & Kline, J. P. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1278332 · Cited by 39
Müller, L. M. E., Holmes, M., Michael, J. L., Scott, G. B., West, E. J., Scott, K. J., Parrish, C., Hall, K., Stäble, S., Jennings, V. A., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0632-y · Cited by 34
Self-citationFragale, A., Romagnoli, G., Licursi, V., Buoncervello, M., Vecchio, G. D., Giuliani, C., Parlato, S., Leone, C., Angelis, M. D., Canini, I., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0080 · Cited by 33
Self-citationSonnemann, J., Greßmann, S., Becker, S., Wittig, S., Schmudde, M., & Beck, J. F. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1302-4 · Cited by 32
Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research
Galuschka, C., Proynova, R., Roth, B., Augustin, H. G., & Müller‐Decker, K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3099 · Cited by 32
Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death
Liu, C.-C., Leclair, P., Pedari, F., Vieira, H. M., Monajemi, M., Sly, L. M., Reid, G. S. D., & Lim, C. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00411 · Cited by 32
Monitoring autophagy in cancer: From bench to bedside
Long, M., & McWilliams, T. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.016 · Cited by 30
The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy
Han, J., & Lotze, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_17 · Cited by 30
Self-citationMelis, M. H. M., Simpson, K., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., Honeychurch, J., & Illidge, T. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.8 · Cited by 23
Self-citationSeitz, C., Rückert, M., Deloch, L., Weiss, E., Utz, S. G., Izydor, M., Ebel, N., Schlücker, E., Fietkau, R., Gaipl, U. S., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00805 · Cited by 22
Self-citationBNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
Romano, E., Rufo, N., Korf, H., Mathieu, C., Garg, A. D., & Agostinis, P. (2018) · Oncotarget · doi:10.18632/oncotarget.24815 · Cited by 20
Self-citationFluorescent Biosensors for the Detection of HMGB1 Release
Martins, I., Kepp, O., Menger, L., Michaud, M., Adjemian, S., Sukkurwala, A. Q., Vacchelli, E., Galluzzi, L., & Kroemer, G. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-383-1_4 · Cited by 19
Self-citationNovel technique for high-precision stereotactic irradiation of mouse brains
Hartmann, J., Wölfelschneider, J., Stache, C., Buslei, R., Derer, A., Schwarz, M. A., Bäuerle, T., Fietkau, R., Gaipl, U., Bert, C., et al. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-1014-8 · Cited by 19
Self-citationProteogenomic discovery of cancer antigens: Neoantigens and beyond
Kanaseki, T., Tokita, S., & Torigoe, T. (2019) · Pathology International · doi:10.1111/pin.12841 · Cited by 13
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationImmunogenic cell stress and death
Kroemer, G., Galassi, C., Zitvogel, L., & Galluzzi, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01132-2 · Cited by 1,353
Self-citationImmunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349
Self-citationFerroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138
Self-citation
Metadata
- Authors
- Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., Draganov, D., Edelson, R. L., Formenti, S. C., Fucikova, J., Gabriele, L., Gaipl, U. S., Gameiro, S. R., Garg, A. D., Golden, E., Han, J., Harrington, K. J., Hemminki, A., Hodge, J. W., Hossain, D. M. S., Illidge, T., Karin, M., Kaufman, H. L., Kepp, O., Kroemer, G., Lasarte, J. J., Loi, S., Lotze, M. T., Manic, G., Merghoub, T., Melcher, A. A., Mossman, K. L., Prosper, F., Rekdal, Ø., Rescigno, M., Riganti, C., Sistigu, A., Smyth, M. J., Spisek, R., Stagg, J., Strauss, B. E., Tang, D., Tatsuno, K., van Gool, S. W., Vandenabeele, P., Yamazaki, T., Zamarin, D., Zitvogel, L., Cesano, A., & Marincola, F. M.
- Venue
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Published
- 2020-03
- Volume
- 8
- Issue
- 1
- Pages
- e000337
- ISSN
- 2051-1426 (ISSN-L)
- OpenAlex
- W3011642937
- Cited by
- 1,119
- References
- 332
- FWCI
- 45.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.